What is Axtria?
Founded in 2010 by Jassi Chadha, Axtria specializes in delivering enterprise-grade, cloud-based software solutions designed to optimize the commercial journey for life sciences organizations. The company addresses the critical need for data-driven decision-making in an era of rapid digitization. By integrating advanced analytics into existing customer ecosystems, Axtria enables its clients to enhance operational efficiency, improve healthcare outcomes, and drive product sales across more than 75 countries. Its platform serves as a foundational layer for companies looking to manage the massive influx of data inherent in global healthcare markets.
How much funding has Axtria raised?
Axtria has raised a total of $377.8M across 10 funding rounds:
Private Equity
$4.3M
Series A
$2.5M
Private Equity
$4.8M
Private Equity
$5.6M
Multiple Rounds
$55.6M
Debt
$5M
Private Equity
$150M
Private Equity
$150M
Private Equity (2009): $4.3M, investors not publicly disclosed
Series A (2010): $2.5M led by Sequoia Capital India
Private Equity (2013): $4.8M, investors not publicly disclosed
Private Equity (2014): $5.6M, investors not publicly disclosed
Series B (2015): $5.6M, investors not publicly disclosed
Private Equity (2015): $20M, investors not publicly disclosed
Series C (2015): $30M led by Helion Ventures
Debt (2020): $5M supported by PPP
Private Equity (2021): $150M featuring Bain Capital Tech Opportunities
Private Equity (2021): $150M backed by Bain Capital Tech Opportunities
Key Investors in Axtria
Sequoia Capital India
A premier venture capital firm managing significant funds in India, focusing on long-term partnerships with entrepreneurs across venture, growth, and late-stage opportunities.
Bain Capital Tech Opportunities
A specialized investment arm of Bain Capital that focuses on identifying and scaling high-growth technology companies with transformative potential.
Helion Ventures
A multi-stage, India-focused venture fund that invests in technology-powered businesses and consumer services, backed by respected global institutional investors.
What's next for Axtria?
With the infusion of its latest capital, Axtria is well-positioned to accelerate its product innovation roadmap and expand its global footprint. The company's strategic focus remains on deepening its cloud-native analytics capabilities to meet the evolving demands of the life sciences industry. As the sector continues to prioritize digital transformation, Axtria is expected to leverage this financing to scale its operations, enhance its software suite, and maintain its competitive edge in the high-growth market of commercial operations technology.
See full Axtria company page
